Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael I Koukourakis

Showing results (1-10 of 238) with videos related to

Pageof 24
Sort By:
Dose-Response : a Publication of International Hormesis Society|September 18, 2020
Low-Dose Radiotherapy for Late-Stage COVID-19 Pneumonia?Michael I Koukourakis
Seminars in Oncology|January 17, 2004
Amifostine: is there evidence of tumor protection?Michael I Koukourakis
Seminars in Oncology|February 11, 2003
Hypofractionated and accelerated radiotherapy with amifostine cytoprotection (HypoARC): a new concept in radiotherapy and encouraging results in breast cancerMichael I Koukourakis
Critical Reviews in Oncology/Hematology|January 22, 2021
Lymphopenia and intratumoral lymphocytic balance in the era of cancer immuno-radiotherapyMichael I Koukourakis, Alexandra Giatromanolaki
Anti-Cancer Drugs|January 24, 2006
Amifostine administration during radiotherapy for cancer patients with genetic, autoimmune, metabolic and other diseasesMichael I Koukourakis, Efstratios Maltezos
International Journal of Radiation Biology|June 19, 2018
Warburg effect, lactate dehydrogenase, and radio/chemo-therapy efficacyMichael I Koukourakis, Alexandra Giatromanolaki
Biochimica Et Biophysica Acta. Reviews on Cancer|March 1, 2022
Tumor draining lymph nodes, immune response, and radiotherapy: Towards a revisal of therapeutic principlesMichael I Koukourakis, Alexandra Giatromanolaki
Cancer Treatment Reviews|November 1, 2005
Preventing radiation induced xerostomiaMichael I Koukourakis, Vassilios Danielidis
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|March 12, 2014
Gamma histone 2AX (γ-H2AX)as a predictive tool in radiation oncologyStamatia Pouliliou, Michael I Koukourakis
Anticancer Research|June 3, 2006
External beam radiotherapy for prostate cancer: current position and trendsMichael I Koukourakis, Stavros Touloupidis
Pageof 24

Showing results (1-10 of 238) with videos related to

Sort By:
Pageof 24
Dose-Response : a Publication of International Hormesis Society|September 18, 2020
Low-Dose Radiotherapy for Late-Stage COVID-19 Pneumonia?Michael I Koukourakis
Seminars in Oncology|January 17, 2004
Amifostine: is there evidence of tumor protection?Michael I Koukourakis
Seminars in Oncology|February 11, 2003
Hypofractionated and accelerated radiotherapy with amifostine cytoprotection (HypoARC): a new concept in radiotherapy and encouraging results in breast cancerMichael I Koukourakis
Critical Reviews in Oncology/Hematology|January 22, 2021
Lymphopenia and intratumoral lymphocytic balance in the era of cancer immuno-radiotherapyMichael I Koukourakis, Alexandra Giatromanolaki
Anti-Cancer Drugs|January 24, 2006
Amifostine administration during radiotherapy for cancer patients with genetic, autoimmune, metabolic and other diseasesMichael I Koukourakis, Efstratios Maltezos
International Journal of Radiation Biology|June 19, 2018
Warburg effect, lactate dehydrogenase, and radio/chemo-therapy efficacyMichael I Koukourakis, Alexandra Giatromanolaki
Biochimica Et Biophysica Acta. Reviews on Cancer|March 1, 2022
Tumor draining lymph nodes, immune response, and radiotherapy: Towards a revisal of therapeutic principlesMichael I Koukourakis, Alexandra Giatromanolaki
Cancer Treatment Reviews|November 1, 2005
Preventing radiation induced xerostomiaMichael I Koukourakis, Vassilios Danielidis
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|March 12, 2014
Gamma histone 2AX (γ-H2AX)as a predictive tool in radiation oncologyStamatia Pouliliou, Michael I Koukourakis
Anticancer Research|June 3, 2006
External beam radiotherapy for prostate cancer: current position and trendsMichael I Koukourakis, Stavros Touloupidis
Pageof 24